News
Key messages • Intravenous immunoglobulin (IVIg) leads to improvement in disability for at least two to six weeks compared with dummy treatment. • During this time period, IVIg is probably equally ...
Craig 'Zeb' Nolte, 56, died this month after he was bitten by a bat when he tried to set the creature free after it became stuck in the verandah of his home in New South Wales, Australia ...
A father-of-two who died after being bitten by a bat has been identified, with his grieving wife claiming health authorities ...
A family was left devastated after a dad-of-two contracted a deadly disease similar to rabies when he was bitten by a rabid bat as he tried to remove it from his home ...
Health authorities are investigating the “breakthrough” infection that led to Ballina tradie Craig Nolte’s death – NSW’s first from the rare bat lyssavirus.
GAITHERSBURG, Md., July 08, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification has been secured to deliver CNJ-016 ® [Vaccinia Immune Globulin ...
Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts ...
Takeda Announces U.S. FDA Approval of GAMMAGARD LIQUID ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content¹ ...
OSAKA, Japan & CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID ERC [immune globulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results